Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

461 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort.
Yang J, Burrello J, Goi J, Reincke M, Adolf C, Asbach E, Brűdgam D, Li Q, Song Y, Hu J, Yang S, Satoh F, Ono Y, Libianto R, Stowasser M, Li N, Zhu Q, Hong N, Nayak D, Puar TH, Wu VC, Vaidya A, Araujo-Castro M, Kocjan T, O'Toole SM, Hundemer GL, Ragnarsson O, Lacroix A, Larose S, Nakai K, Nishikawa T, Ladygina D, Turcu AF, Sholinyan J, Fardella CE, Uslar T, Quinkler M, Mulatero P, Pintus G, Rossi GP, Hahner S, Amar L, Drake WM, Varsani C, Brown MJ, Wu X, Deinum J, Freel EM, Kline G, Naruse M, Prejbisz A, Young WF Jr, Williams TA, Fuller PJ. Yang J, et al. Among authors: o toole sm. Lancet Diabetes Endocrinol. 2025 Jan 14:S2213-8587(24)00308-5. doi: 10.1016/S2213-8587(24)00308-5. Online ahead of print. Lancet Diabetes Endocrinol. 2025. PMID: 39824204
Biomarkers in high grade serous ovarian cancer.
Bates M, Mohamed BM, Lewis F, O'Toole S, O'Leary JJ. Bates M, et al. Among authors: o toole s. Biochim Biophys Acta Rev Cancer. 2024 Nov;1879(6):189224. doi: 10.1016/j.bbcan.2024.189224. Epub 2024 Nov 23. Biochim Biophys Acta Rev Cancer. 2024. PMID: 39581234 Review.
How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona Meeting.
Sehouli J, Boer J, Brand AH, Oza AM, O'Donnell J, Bennett K, Glaspool R, Lee CK, Ethier JL, Harter P, Seebacher-Shariat V, Chang TC, Cohen PA, van Gorp T, Chavez-Blanco A, Welch S, Hranovska H, O'Toole S, Lok CAR, Madariaga A, Rauh-Hain JA, Perez Fidalgo A, Tan D, Michels J, Pothuri B, Fujiwara N, Rosengarten O, Nishio H, Kim SI, Mukopadhyay A, Piovano E, Cecere SC, Kohn EC, Mukherjee U, Nasser S, Lindemann K, Croke J, Chen X, Geissler F, Bookman MA. Sehouli J, et al. Among authors: o toole s. Int J Gynecol Cancer. 2024 Nov 4;34(11):1677-1684. doi: 10.1136/ijgc-2024-005982. Int J Gynecol Cancer. 2024. PMID: 39496422 Free PMC article.
Biobanking rare gynaecological tumours - How harmonised is data collection?
O'Toole S, Tzortzatou O, Casati S, Beirne JP, Savona-Ventura C, Azzopardi MJ, Micallef R, Calleja-Agius J, Ellul B. O'Toole S, et al. Eur J Surg Oncol. 2024 Oct 24:108784. doi: 10.1016/j.ejso.2024.108784. Online ahead of print. Eur J Surg Oncol. 2024. PMID: 39488492
461 results